Cargando…

Thrombotic microangiopathy induced by interferon beta in patients with multiple sclerosis: three cases treated with eculizumab

BACKGROUND: Interferon-beta (IFN-beta) is one of the most widely prescribed medications for relapsing-remitting multiple sclerosis (RRMS). IFN-related thrombotic microangiopathy (TMA) is a rare but severe complication, with a fulminant clinical onset and a possibly life-threatening outcome that may...

Descripción completa

Detalles Bibliográficos
Autores principales:	Allinovi, Marco, Cirami, Calogero Lino, Caroti, Leonardo, Antognoli, Giulia, Farsetti, Silvia, Amato, Maria Pia, Minetti, Enrico Eugenio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2017
Materias:	Thrombotic Microangiopathy
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5622889/ https://www.ncbi.nlm.nih.gov/pubmed/28980667 http://dx.doi.org/10.1093/ckj/sfw143

Ejemplares similares

Thrombotic microangiopathy and human immunodeficiency virus in the era of eculizumab
por: Jin, Anna, et al.
Publicado: (2016)

An updated classification of thrombotic microangiopathies and treatment of complement gene variant-mediated thrombotic microangiopathy
por: Aigner, Christof, et al.
Publicado: (2019)

Relapsing thrombotic microangiopathy and intravenous sustained-release oxycodone
por: Nataatmadja, Melissa, et al.
Publicado: (2016)

Complement C5-inhibiting therapy for the thrombotic microangiopathies: accumulating evidence, but not a panacea
por: Brocklebank, Vicky, et al.
Publicado: (2017)

Pneumococcal hemolytic uremic syndrome and steroid resistant nephrotic syndrome
por: Groves, Andrew P., et al.
Publicado: (2016)

Atypical hemolytic uremic syndrome: a syndrome in need of clarity
por: Berger, Bruce E
Publicado: (2018)

Broad spectrum of interferon-related nephropathies-glomerulonephritis, systemic lupus erythematosus-like syndrome and thrombotic microangiopathy: A case report and review of literature
por: Gianassi, Iacopo, et al.
Publicado: (2019)

Safety and Efficacy of Eculizumab Therapy in Multiple Sclerosis: A Case Series
por: Allinovi, Marco, et al.
Publicado: (2021)

Eculizumab in chemotherapy-induced thrombotic microangiopathy
por: Schulte-Kemna, Lena, et al.
Publicado: (2020)

Eculizumab in gemcitabine-induced thrombotic microangiopathy: experience of the French thrombotic microangiopathies reference centre
por: Grall, Maximilien, et al.
Publicado: (2021)

The use of eculizumab in gemcitabine induced thrombotic microangiopathy
por: Krishnappa, Vinod, et al.
Publicado: (2018)

The Use of Eculizumab in Tacrolimus-Induced Thrombotic Microangiopathy
por: Gabr, Jihad Ben, et al.
Publicado: (2020)

Thrombotic microangiopathy associated with use of interferon-beta
por: Olea, Teresa, et al.
Publicado: (2012)

Posttransplant outcome of atypical haemolytic uraemic syndrome in a patient with thrombomodulin mutation: a case without recurrence
por: Caroti, Leonardo, et al.
Publicado: (2015)

Scleroderma Renal Crisis With Thrombotic Microangiopathy Treated With Eculizumab
por: Saba, Ludovic, et al.
Publicado: (2022)

Hemolytic uremic syndrome and kidney transplantation in uncontrolled donation after circulatory death (DCD): A two-case report
por: Caroti, Leonardo, et al.
Publicado: (2021)

Eculizumab for complement mediated thrombotic microangiopathy in sickle cell disease
por: Chonat, Satheesh, et al.
Publicado: (2020)

Use of Eculizumab in Pediatric Patients With Transplant Associated Thrombotic Microangiopathy
por: Gomez-Ganda, Laura, et al.
Publicado: (2021)

Eculizumab prevents thrombotic microangiopathy in patients with atypical haemolytic uraemic syndrome in a long-term observational study
por: Menne, Jan, et al.
Publicado: (2018)

Thrombotic Microangiopathy in Interferon‐beta‐Treated Multiple Sclerosis Patient
por: Malekzadeh, Masoud Mohammad, et al.
Publicado: (2020)

Eculizumab for Severe Thrombotic Microangiopathy Secondary to Surgical Invasive Stress and Bleeding
por: Fujita, Yoko, et al.
Publicado: (2020)

Treatment of Gemcitabine-Induced Thrombotic Microangiopathy Followed by Gemcitabine Rechallenge With Eculizumab
por: Efe, Orhan, et al.
Publicado: (2021)

Complement inhibitor eculizumab in thrombotic microangiopathy: Single‐center case series
por: Vitkauskaitė, Monika, et al.
Publicado: (2022)

Bevacizumab-Associated Thrombotic Microangiopathy Treated with Eculizumab: A Case Report
por: Padilha, Wallace Stwart Carvalho, et al.
Publicado: (2023)

Gemcitabine-induced thrombotic microangiopathy treated with eculizumab: a case report
por: Van den Eeckhaut, Lisa, et al.
Publicado: (2022)

Drug-induced thrombotic microangiopathy: An updated review of causative drugs, pathophysiology, and management
por: Mazzierli, Tommaso, et al.
Publicado: (2023)

Thrombotic microangiopathy associated with interferon-beta treatment in patients with multiple sclerosis
por: Baghbanian, Seyed Mohammad, et al.
Publicado: (2018)

De novo collapsing glomerulopathy after kidney transplantation: Description of two cases
por: Cutruzzulà, Roberta, et al.
Publicado: (2023)

Gemcitabine and carfilzomib induced thrombotic microangiopathy: eculizumab as a life‐saving treatment
por: Gosain, Rahul, et al.
Publicado: (2017)

The use of eculizumab in Capnocytophaga canimorsus associated thrombotic microangiopathy: a case report
por: Bjørkto, Magnus Holter, et al.
Publicado: (2021)

Eculizumab for rescue of thrombotic microangiopathy in PM-Scl antibody-positive autoimmune overlap syndrome
por: Thomas, Christie P., et al.
Publicado: (2015)

Scleroderma Renal Crisis Debute with Thrombotic Microangiopathy: A Successful Case Treated with Eculizumab
por: Uriarte, Maite Hurtado, et al.
Publicado: (2018)

Treatment of Chemotherapy-Induced Thrombotic Microangiopathy with Eculizumab in a Patient with Metastatic Breast Cancer
por: Hausberg, Martin, et al.
Publicado: (2019)

A systematic review of the role of eculizumab in systemic lupus erythematosus-associated thrombotic microangiopathy
por: Wright, Rachael D., et al.
Publicado: (2020)

Two cases of carfilzomib‐induced thrombotic microangiopathy successfully treated with Eculizumab in multiple myeloma
por: Rassner, Michael, et al.
Publicado: (2021)

Eculizumab precision-dosing algorithm for thrombotic microangiopathy in children and young adults undergoing HSCT
por: Mizuno, Kana, et al.
Publicado: (2022)

Renal thrombotic microangiopathy induced by β-interferon
por: Li Cavoli, Gioacchino, et al.
Publicado: (2011)

Renal thrombotic microangiopathy caused by interferon beta-1a treatment for multiple sclerosis
por: Mahe, Julien, et al.
Publicado: (2013)

Eculizumab for Thrombotic Microangiopathy Associated with Antibody-Mediated Rejection after ABO-Incompatible Kidney Transplantation
por: Lanfranco, Luca, et al.
Publicado: (2017)

Role of eculizumab in a pediatric refractory gemcitabine-induced thrombotic microangiopathy: a case report
por: Facchini, Ludovica, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_grg1079mnvfqv2fuskiapdt0f2